Large Sponsors | Clinical Research Workflow Solutions for Large Industry SponsorsBlake Adams2022-12-14T13:10:18-05:00
Industries > Large Sponsors
Activate Remote, Always-on Workflows with Your Study Sites on a Global Scale
Global biopharmaceutical and medical device research sponsors depend on Florence to enable always-on remote workflows with their study sites. Florence’s digital workflows and established global presence enable sponsors to quickly adapt to the new remote-first model of research operations.
Florence facilitates 3 million remote workflows every month across 10,000 study sites in 45 countries.
How Florence Helps Large Biopharma and Medical Device Companies
Make Sites Happier
When you partner with Florence to deploy research workflows to your sites, you give them a platform they love. Florence eBinders is ranked #1 for clinical trial workflows by sites for ease-of-use, ease-of-setup and support.
Expand Patient Access
Deploying remote digital workflows to sites means you can expand access to a geographically disperse site network. Active sites on Florence already are within 25 miles of 90% of the US population.
Maximize CRA Efficiency
CRAs with remote access capabilities can monitor over 60 sites per week with Florence. CRA staffing bottlenecks and travel costs are reduced, and CRAs can make a greater impact on study sites.
Improve eTMF Quality
Over 80% of your eTMF is generated at the trial site. By integrating site workflows with your eTMF through Florence, you can exchange documents seamlessly. The eTMF pass rate of one customer increased from 65% to 98.7%.
Activate Sites Fast
Coupling our existing global network of connected sites with our #1-ranked site activation team, we set up your sites indays with a 92%+ site acceptance rate on Florence eBinders™, the industry-standard eISF and Electronic Participant Binder for sites.
Accelerate Study Timelines
Automated workflows like electronic logs, placeholders, eSignatures and quality assurance workflows reduce start-up times by 40% for most of our customers and accelerate overall study timelines to reduce time to submission.
Florence’s platform is helping Pfizer to respond to the changing environment due to COVID-19 and further progress COVID-19 research with the capability to perform remote monitoring where approved by regulatory authorities and ethics committees.
Rob Goodwin VP and Head of Operations in Global Product Development Pfizer
According to user reviews, Florence is rated the #1 clinical trial workflows platform for ease-of-setup, ease-of-use and customer support.
Why being rated #1 out of 190 clinical trial platforms on G2, the peer-to-peer review site, matters for you.
High Adoption: We lead the industry with 92%+ site technology activation per study.
Faster Timelines: Intuitive workflows that eliminate duplicate work mean work gets done fast.
Low FTE Burden: You don’t need large dedicated IT teams to support implementation and management.
Always Reliable: Our customers have had 100% uptime over the last 12 months. We’re there when you need us.
We are committed to making you and your sites successful.
Site Adoption Rate
Uptime Past 12 Months
Avg. Support Response Time
Florence’s SiteLink™ Remote, Always-On Research Workflows with Your Study Sites
Activate remote site start-up, monitoring, and source data review/verification on SiteLink. Connect and deploy Florence eBinders™, the industry-standard electronic Investigator Site File and Electronic Participant Binder, on a global scale to every site in your study.
In clinical research, compliance is crucial. We’ve got you covered.
Why Large Global Biopharmaceutical and Medical Device Companies Rely on Florence for Always-on, Remote Workflows with Sites
Sites Trust Florence
Sites are tired of sponsors forcing ill-fitting software into their workflows. As a result, sponsors rarely see the value they expect. Florence changes this by designing software for site-first workflows. And they trust us. We’reranked #1 for clinical trial workflows by sites for ease-of-use, ease-of-setup and support.
Today, research is conducted on a global scale, spanning borders, time zones, and regulatory agencies. Florence’s global reach – 10,000 sites in 45 countries – along with a team of regulatory experts and granular access controls enable you to deploy digital infrastructure around the world.
Industry Leader in Support
You benefit from the experience of a team of experts who have helped more than 10,000 clinical trial sites and 30,000 users migrate to digital workflows. This deep understanding of what makes a site successful allows us to provide the most comprehensive support in the industry.
Top Ranked Ease-of-use
When you establish continuous, remote workflows across many study sites around the world, you need an easy-to-use platform. With Florence, you and your sites won’t have to deal with the complex interfaces often associated with clinical software and can instead focus on getting the work done quickly.
Access to the World’s Leading Sites
The world’s leading academic medical centers, cancer institutes, hospitals, healthcare networks, site networks, and independent sites rely on Florence for their workflows. Through Florence, they make their workflows available to you directly.
Scalable Across Organization
Our expert implementation and support teams do all the heavy lifting for you to get your sites up and running, and on average we achieve 92%+ full adoption and activation rates in weeks. No matter if you’re rolling out to 50 locations or 5,000, we’ve got you covered.
“Our highest performing CRAs are now ‘visiting’ 64 sites per week with remote monitoring on Florence, up from 2 per week.”
VP Clin Ops, Top 3 Global CRO
“92% of 140 study sites in 8 countries were activated on Florence for remote source access and monitoring in four weeks.”
VP Clin Ops, Top 3 Pharma
“Our eTMF QA score went from a 65% submission pass rate to 98.7% by having real-time remote access to the site eISF.”
Aperio Clinical Outcomes
Florence Supports Site Enablement on a Global Scale
Florence now supports workflows between sponsors and more than 10,000 study sites in 45 countries.